-
Posted by
Two Blokes Jul 1 -
Filed in
Stock
-
8 views
IonQ's acquisition of Oxford Ionics creates powerful technological synergies, accelerating the path toward commercial quantum computing breakthroughs using complementary ion-trap and semiconductor chip platforms. Recent partnerships with AstraZeneca, AWS, NVIDIA, and Einride demonstrate growing traction and real-world use cases for IonQ's quantum technology in biotech and logistics. Despite minimal current revenue and high dilution, IonQ's strong cash position and venture-scale ambitions justify the risk for investors seeking exposure to a potentially massive $850B quantum market.
